Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II - Tissue distribution

Citation
A. Bargoni et al., Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II - Tissue distribution, PHARMAC RES, 43(5), 2001, pp. 497-502
Citations number
38
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACOLOGICAL RESEARCH
ISSN journal
10436618 → ACNP
Volume
43
Issue
5
Year of publication
2001
Pages
497 - 502
Database
ISI
SICI code
1043-6618(200105)43:5<497:TTOTII>2.0.ZU;2-9
Abstract
Tobramycin-loaded solid lipid nanoparticles (SLN) were prepared and adminis tered by duodenal and intravenous (i.v.) routes to rats and the tissue dist ributions were determined successively at fixed times (30 min, 4 h and 24 h ) and compared to those of the tobramycin solution after i.v. administratio n. The tissue distribution between tobramycin-loaded SLN administered duodenal ly and i.v. was different.. A marked difference between tobramycin-loaded S LN administered duodenally and tobramycin solution administered i.v. was al so evidenced. In particular, the amounts of tobramycin in the kidneys after tobramycin-loaded SLN administration either duodenally or i.v. were lower than after administration of i.v. solution. Tobramycin-loaded SLN were able to pass across the blood-brain barrier in rats to a greater extent after i .v. injection than after duodenal administration. (C) 2001 Academic Press.